The concurrent high expression of disintegrin metalloproteinase 15 (ADAM15) further enhances integrin-dependent tumor growth and metastasis in NSCLC, as ADAM15 is the only member of the metalloproteinase family located on the cell membrane that contains an RGD fragment in the disintegrin domain. Here, ADAM15 is linked to neoplasm.